Sarepta Therapeutics (SRPT) Other Working Capital Changes (2013 - 2026)
Sarepta Therapeutics' quarterly Other Working Capital Changes came in at -$274.9 million in Q1 2026, down 221.93% year-on-year from $225.5 million in Q1 2025, and down 654.37% quarter-over-quarter from $49.6 million in Q4 2025.
Sarepta Therapeutics has reported Other Working Capital Changes for 14 years, with the latest figure at -$274.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 221.93% year-over-year to -$274.9 million; the trailing twelve-month figure through Mar 2026 stood at -$109.7 million (down 333.65% YoY), and the FY2025 full-year result was $69569.0, down 99.28% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$274.9 million, down from $49.6 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $122.7 million in Q2 2025, with the low at -$274.9 million in Q1 2026.
- Average Other Working Capital Changes over 5 years is -$16.3 million, with a median of -$7.1 million recorded in 2025.
- Year-over-year, Other Working Capital Changes plunged 323.9% in 2024 and soared 1122.15% in 2025.
- Tracing SRPT's Other Working Capital Changes over 5 years: stood at -$22.5 million in 2022, then surged by 79.13% to -$4.7 million in 2023, then jumped by 1060.61% to $45.1 million in 2024, then gained by 9.98% to $49.6 million in 2025, then tumbled by 654.37% to -$274.9 million in 2026.
- The last three Other Working Capital Changes figures came in at -$274.9 million (Q1 2026), $49.6 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -274.92 Mn |
| Mar 31, 2026 | -274.92 Mn |
| Dec 31, 2025 | 49.59 Mn |
| Dec 31, 2025 | 49.59 Mn |
| Sep 30, 2025 | -7.07 Mn |
| Sep 30, 2025 | -7.07 Mn |
| Jun 30, 2025 | 122.66 Mn |
| Jun 30, 2025 | 122.66 Mn |
| Mar 31, 2025 | -85.40 Mn |
| Mar 31, 2025 | -85.40 Mn |
| Dec 31, 2024 | 45.09 Mn |
| Dec 31, 2024 | 45.09 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Mar 31, 2024 | -50.42 Mn |
| Mar 31, 2024 | -50.42 Mn |
| Dec 31, 2023 | -4.69 Mn |
| Dec 31, 2023 | -4.69 Mn |
| Sep 30, 2023 | 12.52 Mn |
| Sep 30, 2023 | 12.52 Mn |
| Jun 30, 2023 | -32.15 Mn |
| Jun 30, 2023 | -32.15 Mn |
| Mar 31, 2023 | 22.52 Mn |
| Mar 31, 2023 | 22.52 Mn |
| Dec 31, 2022 | -22.49 Mn |
| Dec 31, 2022 | -22.49 Mn |
| Sep 30, 2022 | -35.83 Mn |
| Sep 30, 2022 | -35.83 Mn |
| Jun 30, 2022 | -8.92 Mn |
| Jun 30, 2022 | -8.92 Mn |
| Mar 31, 2022 | -22.01 Mn |
| Mar 31, 2022 | -22.01 Mn |
| Dec 31, 2021 | -36.45 Mn |
| Dec 31, 2021 | -36.45 Mn |
| Sep 30, 2021 | -22.50 Mn |
| Sep 30, 2021 | -22.50 Mn |
| Jun 30, 2021 | -9.34 Mn |
| Jun 30, 2021 | -9.34 Mn |
| Mar 31, 2021 | -34.92 Mn |
| Mar 31, 2021 | -34.92 Mn |
| Dec 31, 2020 | 635.30 Mn |
| Dec 31, 2020 | 635.30 Mn |
| Sep 30, 2020 | -680.36 Mn |
| Sep 30, 2020 | -680.36 Mn |
| Jun 30, 2020 | -25.95 Mn |
| Jun 30, 2020 | -25.95 Mn |
| Mar 31, 2020 | 820.44 Mn |
| Mar 31, 2020 | 820.44 Mn |
| Dec 31, 2019 | 7.38 Mn |
| Dec 31, 2019 | 7.38 Mn |
| Sep 30, 2019 | 7.00 Mn |
| Sep 30, 2019 | 7.00 Mn |
| Jun 30, 2019 | 87.03 Mn |
| Jun 30, 2019 | 87.03 Mn |
| Mar 31, 2019 | 682,000.00 |
| Mar 31, 2019 | 682,000.00 |
| Dec 31, 2018 | 52.29 Mn |
| Dec 31, 2018 | 52.29 Mn |
| Sep 30, 2018 | 54.48 Mn |
| Sep 30, 2018 | 54.48 Mn |
| Jun 30, 2018 | 34.54 Mn |
| Jun 30, 2018 | 34.54 Mn |
| Mar 31, 2018 | -4.67 Mn |
| Mar 31, 2018 | -4.67 Mn |
| Dec 31, 2017 | 8.04 Mn |
| Dec 31, 2017 | 8.04 Mn |
| Sep 30, 2017 | -1.97 Mn |
| Sep 30, 2017 | -1.97 Mn |
| Jun 30, 2017 | 10.06 Mn |
| Jun 30, 2017 | 10.06 Mn |
| Mar 31, 2017 | -774,000.00 |
| Mar 31, 2017 | -774,000.00 |
| Dec 31, 2016 | 809,000.00 |
| Dec 31, 2016 | 809,000.00 |
| Sep 30, 2016 | 7.81 Mn |
| Sep 30, 2016 | 7.81 Mn |
| Jun 30, 2016 | -2.79 Mn |
| Jun 30, 2016 | -2.79 Mn |
| Mar 31, 2016 | 3.18 Mn |
| Mar 31, 2016 | 3.18 Mn |
| Dec 31, 2015 | -5.29 Mn |
| Dec 31, 2015 | -5.29 Mn |
| Sep 30, 2015 | -1.27 Mn |
| Sep 30, 2015 | -1.27 Mn |
| Jun 30, 2015 | -1.28 Mn |
| Jun 30, 2015 | -1.28 Mn |
| Mar 31, 2015 | -7.41 Mn |
| Mar 31, 2015 | -7.41 Mn |
| Dec 31, 2014 | 4.85 Mn |
| Dec 31, 2014 | 4.85 Mn |
| Sep 30, 2014 | 9.91 Mn |
| Sep 30, 2014 | 9.91 Mn |
| Jun 30, 2014 | 13.24 Mn |
| Jun 30, 2014 | 13.24 Mn |
| Mar 31, 2014 | 6.02 Mn |
| Mar 31, 2014 | 6.02 Mn |
| Dec 31, 2013 | -129,000.00 |
| Dec 31, 2013 | -129,000.00 |